Literature DB >> 12870781

Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.

Tadahiko Masaki1, Masanori Sugiyama, Hiroyoshi Matsuoka, Nobutsugu Abe, Yumi Izumisato, Atsuhiko Sakamoto, Yutaka Atomi.   

Abstract

We attempted to examine the correlation between matrilysin and laminin-5 gamma2 chain expression with reference to the number of dedifferentiation units along the entire invasive front (tumor budding). Immunostaining for hMMP-7 and laminin-5 gamma2 chain was performed in 50 T1 colorectal carcinomas, and immunoreactivity was evaluated at the invasive front of the tumor. On hematoxylin-eosin sections, the number of tumor budding was counted. The localization of matrilysin tended to be widespread compared with that of laminin-5 gamma2 chain. Matrilysin and laminin-5 gamma2 chain expression were positive in 28 (56%) and 15 (30%) tumors respectively. There was a significant correlation between matrilysin and laminin-5 gamma2 chain expression (P = 0.02). Matrilysin(+)/laminin-5 gamma2 chain(+) tumors had a significantly greater amount of tumor budding than matrilysin(-)/laminin-5 gamma2 chain(-) tumors (P = 0.003) or matrilysin(+)/laminin-5 gamma2 chain(-) tumors (P = 0.03). In conclusions, coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870781     DOI: 10.1023/a:1024142722640

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Proteolytic modification of laminins: functional consequences.

Authors:  S Ghosh; M S Stack
Journal:  Microsc Res Tech       Date:  2000-11-01       Impact factor: 2.769

2.  Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.

Authors:  H Yamamoto; F Itoh; S Iku; M Hosokawa; K Imai
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

Review 3.  Biological and clinical relevance of Laminin-5 in cancer.

Authors:  G Giannelli; S Antonaci
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.

Authors:  H Yamamoto; F Itoh; Y Adachi; H Sakamoto; M Adachi; Y Hinoda; K Imai
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

5.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.

Authors:  M Ono; M Sakamoto; Y Ino; Y Moriya; K Sugihara; T Muto; S Hirohashi
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

7.  Purification and properties of a small latent matrix metalloproteinase of the rat uterus.

Authors:  J F Woessner; C J Taplin
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

8.  Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.

Authors:  Y Adachi; F Itoh; H Yamamoto; K Matsuno; Y Arimura; M Kusano; T Endoh; Y Hinoda; M Oohara; M Hosokawa; K Imai
Journal:  Int J Oncol       Date:  1998-11       Impact factor: 5.650

9.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

10.  Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.

Authors:  T Masaki; H Matsuoka; M Sugiyama; N Abe; A Goto; A Sakamoto; Y Atomi
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  10 in total

1.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Serum laminin is an independent prognostic factor in colorectal cancer.

Authors:  Noboru Saito; Shingo Kameoka
Journal:  Int J Colorectal Dis       Date:  2004-12-08       Impact factor: 2.571

3.  Antitumor effects of matrine on cancer stem like cells isolated from the human liver cancer SMMC-7721 cell line.

Authors:  Yong Wang; Yahui Liu; Jianshuai Jiang; Hanbin Cui
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

4.  ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.

Authors:  Lsabel Hostettler; Inti Zlobec; Luigi Terracciano; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

5.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

6.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

7.  Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

Authors:  Sang-Sik Ha; Hong-Jo Choi; Ki-Jae Park; Jung-Min Kim; Sung-Heun Kim; Young-Hoon Roh; Hyuk-Chan Kwon; Mee-Sook Roh
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 8.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

9.  Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

Authors:  S Kazama; T Watanabe; Y Ajioka; T Kanazawa; H Nagawa
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays.

Authors:  Chandra Kirana; Hongjun Shi; Emma Laing; Kylie Hood; Rose Miller; Peter Bethwaite; John Keating; T William Jordan; Mark Hayes; Richard Stubbs
Journal:  Int J Proteomics       Date:  2012-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.